The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Fri., Oct. 21, 7:11 AM

Slide #4. Organovo Holdings, Inc. Secondary Offering

Company: Organovo Holdings, Inc. (NASDAQ:ONVO)
Date announced: 10/19/2016
Shares Offered: 9,000,000
Date of Pricing: 10/20/2016
Price Per Share: $2.75
Secondary Offering Details: Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo"), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced that it has commenced an underwritten public offering of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to the completion, size and terms of the offering. -updated 10/20- Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo"), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced the sale of 9,000,000 shares of its common stock in an underwritten public offering at a price to the public of $2.75 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to 1,350,000 additional shares of its common stock on the same terms and conditions. The gross offering proceeds to Organovo from the sale of the shares are expected to be approximately $25.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses and excluding any proceeds from the exercise of the underwriters' option. The offering is expected to close on or about October 25, 2016, subject to customary closing conditions.

Organovo Holdings is a commercial stage company focused on developing and commercializing functional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. Co.'s platform technology is focused on multiple three dimensional bioprinting technologies, which Co. has used to develop its proprietary instrument platform, its NovoGen Bioprinters®. Co.'s 3D bioprinting technologies enable an array of tissue compositions and architectures to be developed, using cellular bio-ink (building blocks comprised of living cells), biocompatible hydrogels, or combinations of the two.

ONVO SEC Filing Email Alerts Service

Open the ONVO Page at The Online Investor »

Company Name:  Organovo Holdings Inc
Sector:  Biotechnology
Number of ETFs Holding ONVO:  13
Total Market Value Held by ETFs:  $6.86M
Total Market Capitalization:  $327.00M
% of Market Cap. Held by ETFs:  2.10%

Open the ONVO Page at The Online Investor (in a new window) »

October 21, 2016    7:11 AM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
89th percentile
(ranked higher than approx. 89% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.